AUTHORS
Greta Zara, PhD, Sally Mokhtari, PhD2, Katarina Piasevoli, MS3, Monica Torres-Coronado4, Xiu-li Li5, Angelo A Cardoso, MD, PhD6, Ryotaro Nakamura, MD7, Nadia Carlesso, MD, PhD8
AFFILIATIONS
1 City of Hope, Duarte, California, United States
2 City of Hope, Duarte, California, United States
3 City of Hope, Duarte, California, United States
4 City of Hope, Duarte, California, United States
5 City of Hope, Duarte, California, United States
6 City of Hope, Duarte, California, United States
7 City of Hope, Duarte, California, United States
8 City of Hope, Duarte, California, United States
ABSTRACT
Background: Severe aplastic anemia (SAA) is an immune-mediated bone marrow (BM) failure syndrome characterized by destruction of hematopoietic stem and progenitor cells (HSPCs), resulting in hypocellularity and pancytopenia. Although HSPC depletion is central to SAA pathogenesis, the role of BM microenvironment remodeling during recovery after allogeneic hematopoietic cell transplantation (HCT) is poorly defined.
Objective: To characterize longitudinal changes in the BM microenvironment during severe marrow failure and recovery following allogeneic HCT.
Methods: BM and peripheral blood (PB) samples were analyzed from 6 SAA patients before HCT through 1 year post-HCT using multiparameter flow cytometry. Hematopoietic, immune, erythroid, and microenvironment-associated populations were characterized. Pre-transplant BM mesenchymal stromal cells (MSCs) were expanded ex vivo for further characterization.
Results: Prior HCT, all patients demonstrated profound BM hypocellularity with marked depletion of HSPCs. In contrast, CD14-CD11b+ immature myeloid cells were relatively enriched, whereas CD14+CD11b+ monocyte/macrophage-lineage cells were markedly reduced. CD3+ T-cells were expanded in BM and PB, consistent with SAA immune dysregulation.
By day 30 post-HCT, partial BM reconstitution was characterized by increased CD34+CD38+ progenitors and immature myeloid cells, while mature CD14+CD11b+ cells mobilized into PB. However, by day 100 through 1 year, HSPCs and CD14+CD11b+ cells declined, while immature myeloid cells persisted, indicating incomplete recovery. T-cell reconstitution showed sustained CD8+ predominance over CD4+, with up to 93% of BM T-cells expressing CD8. B-cell maturation was also impaired, with persistent accumulation of immature CD10+ B-cells (up to 80% in BM and 89% in PB) and near absence of mature CD20+ B-cells.
To assess changes in the BM microenvironment, CD45 expression was used to distinguish hematopoietic and non-hematopoietic compartments. A distinct CD45dim BM population was identified before HCT in 4 patients, representing ~10-20% of BM cells in most cases and up to 64% in 1 patient. In the remaining 2 patients, it was absent pre-HCT but emerged transiently during early recovery, reaching frequencies of ~45% before becoming undetectable. Higher CD8+/CD4+ ratios were observed in patients with abundant CD45dim cells, including those in whom the population appeared only after HCT. These cells expressed CD271, CD105, and CD31, while lacking cKit, CD34, and CD235a, consistent with a heterogeneous vascular–mesenchymal niche-associated phenotype rather than hematopoietic progenitors or erythroid lineage cells. Serial post-transplant analyses showed a progressive decline in the frequency of the CD45dim population during hematopoietic recovery, while remaining detectable and distinct in all patients in whom it was present at baseline. Throughout these dynamics, mixed stromal/erythroid marker expression remained evident across both CD45- and CD45dim subsets. Following ex vivo expansion, pre-transplant MSCs displayed a conventional phenotype with loss of CD45, CD31, and CD271 and predominance of CD90 expression.
Conclusions: After HCT, hematopoietic and microenvironmental recovery in SAA is accompanied by persistent immune and niche-associated abnormalities. We identified a distinct CD45dim population with vascular-mesenchymal features that was most prominent during severe marrow failure and declined during recovery, with complete resolution in a subset of patients. Its position at the niche-hematopoietic interface, together with mixed stromal/erythroid-associated marker expression, suggests a dynamic niche-associated population that may reflect active remodeling during marrow regeneration. Sustained depletion of mature myeloid cells, persistent CD8+ skewing, and defective B-cell maturation indicate incomplete restoration of marrow architecture despite engraftment.
Significance: These findings identify a novel CD45dim niche-associated population and demonstrate persistent microenvironmental defects despite engraftment, suggesting that BM niche restoration may be an underappreciated determinant of long-term hematopoietic recovery after HCT in SAA. Molecular characterization and scRNA-seq analyses are ongoing to define the functional role of this population and evaluate its potential utility as a biomarker of marrow regeneration and a target for niche-directed therapies to improve post-transplant outcomes.
DISCLOSURES
Greta Zara, PhD: No relevant conflicts of interest to declare.